J&J Hit With $70 Million Risperdal Verdict Over Male Breasts

July 2016

Bloomberg reports: “A $70 million verdict won by a Tennessee teenager who blamed Johnson & Johnson’s Risperdal drug for causing him to grow female breasts dwarfs awards to other users of the antipsychotic medication who suffered the same side effect.”